| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | – | – | – | – | – |
| R&D | $591.00K | $451.07K | $329.19K | $316.71K | – |
| SG&A | $11.93M | $11.21M | $11.52M | $5.72M | $456.76K |
| Operating Income | -$16.45M | -$11.66M | -$10.55M | -$5.72M | -$456.76K |
| Interest Expense | – | $0.00 | $236.70K | – | – |
| Tax Expense | $106.00K | $51.47K | $166.26K | $431.63K | – |
| Net Income | -$6.96M | -$3.33M | -$2.74M | -$3.70M | -$474.58K |
| EPS (basic) | – | – | – | – | – |
| EPS (diluted) | – | -0.5300 | -0.4500 | – | -0.0500 |
| Shares (diluted) | – | $6.29M | $6.14M | – | $4.03M |